drugset

drugset / Trial / NCT00946686

To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions

NCT00946686 ↗

Phase 1 Completed 52 enrolled Sandoz

RandomizedParallel-groupOpen-labelTreatment

Summary

To demonstrate the relative bioavailability, parallel study Of Leflunomide 20 mg tablets under fasting conditions.

Timeline

Start: 2002-09
Primary completion: 2002-09
Completion: 2002-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Leflunomide	Small molecule	20 mg	—

Indications